Five years ago, politicians and bureaucrats went berserk and pointlessly ravaged Americans’ freedom. The Covid-19 pandemic taught that in the long run, people have more to fear from politicians than from viruses.--Boyard
***
In the last 18 months, there have been 250 attacks by Houthis on international shipping.
***
The government added $838 billion to the national debt in the first four months of fiscal 2025 (October through January).
***
Oliver Stone is back with a new JFK routine.
***
We are no longer subjected to incremental amaturism in politics; with tariffs, Trump has us fully committed.
***
mRNA Cancer Vaccines
With the help of mRNA technology proven effective during the COVID-19 pandemic, researchers are now closer than ever to creating viable cancer vaccines.
In an interview with Wired, Lennard Lee, an oncologist with the United Kingdom's National Health Service (NHS) working on mRNA cancer vaccines, says he believes the groundbreaking research may prove to be a "silver lining" in the brutal COVID-19 pandemic.
Before COVID, as Lee told the magazine, "cancer vaccines weren’t a proper field of research."
"Pretty much every clinical trial had failed," the NHS oncologist said. "With the pandemic, however, we proved that mRNA vaccines were possible."
As with mRNA COVID vaccines, the logistics of these potential new cancer inoculations work by "giving the body instructions" to fight troublesome cells, as Lee detailed, ultimately providing the immune system with a how-to manual on fighting cancer.
"Going from mRNA Covid vaccines to mRNA cancer vaccines is straightforward," he told Wired. "Same fridges, same protocol, same drug, just a different patient."
Instead of the one-size-fits-all approach taken with the widespread usage of mRNA COVID jabs, however, these new cancer vaccines will be personalized for each individual cancer patient.
"In the current trials," Lee elucidated, "we do a biopsy of the patient, sequence the tissue, send it to the pharmaceutical company, and they design a personalized vaccine that’s bespoke to that patient’s cancer."
"That vaccine is not suitable for anyone else," he recounted to the magazine. "It’s like science fiction."
According to Lee, breakthrough cancer vaccine innovation came on the heels of the UK's rapid infrastructure-building during the COVID pandemic, which saw the country "open and deliver clinical trials" much faster than anyone would have expected.